Extensions

Patent Term Adjustments (PTA) and Patent Term Extensions (PTE) for US10771069

Patent Term Adjustment (PTA):
US Patent 10771069 was granted Patent Term Adjustment (PTA). PTA is granted to compensate patent applicants for certain delays incurred by the USPTO during the patent prosecution process. The total PTA is added to the standard 20-year patent term from the earliest filing date. This adjustment is calculated based on specific timeframes the USPTO must meet for actions like issuing office actions, responding to applicant replies, and issuing the patent after the issue fee is paid.

To determine the exact PTA for US10771069, one would typically refer to the "Issue Notification" or the "Patent" document itself, which provides the calculated PTA. Without direct access to this specific document, the precise number of days cannot be definitively stated here.

Patent Term Extension (PTE):
Patent Term Extensions (PTEs) are generally available for patents covering human drugs, food or color additives, medical devices, animal drugs, and veterinary biological products to restore term lost due to premarket government approval delays from regulatory agencies like the FDA. Given the nature of US10771069, which relates to a field-programmable gate array (FPGA) system and high-frequency trading applications, it is highly unlikely to be eligible for a Patent Term Extension under 35 U.S.C. § 156. There is no information in the patent document or general patent records to suggest that US10771069 has received or is eligible for PTE.

Continuation and Divisional Applications

• Continuation Applications: A continuation application is a patent application based on an original "parent" application, sharing the same priority date and specification. It allows the applicant to pursue additional claims to an invention disclosed in the parent application that may not have been allowed or fully explored in the parent. These can be filed as long as at least one patent application in the family is pending.
• Divisional Applications: A divisional application is filed when a parent application contains claims directed to more than one distinct invention, and the USPTO issues a "restriction requirement" forcing the applicant to choose which invention to pursue in the parent. The claims for the non-elected invention(s) can then be pursued in one or more divisional applications. Divisional applications also share the same disclosure and priority date as the parent.

To determine if US10771069 is a continuation, divisional, or has any such applications, one would typically examine the "Related U.S. Application Data" section of the patent's front page. Based on the provided patent information, US10771069 lists several priority claims:

• Priority to US16/670,702 (2019-10-31)
• Priority to US16/888,218 (2020-05-29)
• Priority to US16/937,309 (2020-07-23)
• Priority to US17/236,577 (2021-04-21)
• Priority to US17/723,130 (2022-04-18)

These priority claims indicate that US10771069 is part of a patent family and claims priority back to at least application US16/670,702. The language "Priority to" typically signifies that these are either continuation, continuation-in-part, or divisional applications of earlier-filed applications. Without reviewing the complete prosecution history for each, it's difficult to definitively categorize each relationship (e.g., whether a restriction requirement led to a divisional, or if it's a straightforward continuation).

Related Family Members

The listed priority claims (US16/670,702, US16/888,218, US16/937,309, US17/236,577, US17/723,130) identify other applications in the patent family of US10771069. These applications are "related family members" as they share a common lineage and priority date with US10771069.

• US10771069B1
• US16/670,702
• US201916670702A
• US10771069 B1
• US 201916670702 A
• US10763865B1
• US11018678B1
• US11329655B1
• US12107587B1

It is important to note that the listed "Publication number" (US10771069B1) and "Application number" (US16/670,702) for US10771069 are directly associated with this patent. The other patent numbers like US10763865B1, US11018678B1, US11329655B1, and US12107587B1 are listed under "Priority to" and are therefore other issued patents or published applications that claim priority from the same lineage.

Projected Expiration Date

The standard term for a U.S. patent is 20 years from the filing date of the earliest non-provisional application in its family, subject to any Patent Term Adjustments (PTA) or Patent Term Extensions (PTE).

The filing date of US10771069 is October 31, 2019. The provided patent information states a "Priority date" of February 21, 2019. If this is the earliest effective filing date from which the 20-year term is calculated, then the base expiration date would be February 21, 2039.

However, the "Anticipated expiration" date is explicitly stated as 2039-10-31. This suggests that the 20-year term is being calculated from the filing date of the specific application that led to US10771069 (US16/670,702, filed 2019-10-31), rather than the earlier priority date of February 21, 2019. The discrepancy between the priority date and filing date for the 20-year term calculation often depends on whether the claims are fully supported by the earliest priority application.

Therefore, based on the explicitly stated "Anticipated expiration" date:

• Projected Expiration Date: October 31, 2039.

This date accounts for the standard 20-year term from the filing date (October 31, 2019) of the application US16/670,702, from which US10771069 directly matured. If there was any PTA, it would be added to this date. Without the specific PTA value, the given "Anticipated expiration" date is taken as the best current estimate.